74 related articles for article (PubMed ID: 2184324)
21. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
22. Locus specificity of mutagenicity of 2,4-diaminotoluene in both L5178Y mouse lymphoma and AT3-2 Chinese hamster ovary cells.
Coppinger WJ; Brennan SA; Carver JH; Thompson ED
Mutat Res; 1984 Feb; 135(2):115-23. PubMed ID: 6694660
[TBL] [Abstract][Full Text] [Related]
23. Relationships between benzo(a)pyrene-DNA adduct levels and genotoxic effects in mammalian cells.
Arce GT; Allen JW; Doerr CL; Elmore E; Hatch GG; Moore MM; Sharief Y; Grunberger D; Nesnow S
Cancer Res; 1987 Jul; 47(13):3388-95. PubMed ID: 3581076
[TBL] [Abstract][Full Text] [Related]
24. S-oxygenation of thiourea results in the formation of genotoxic products.
Ziegler-Skylakakis K; Nill S; Pan JF; Andrae U
Environ Mol Mutagen; 1998; 31(4):362-73. PubMed ID: 9654246
[TBL] [Abstract][Full Text] [Related]
25. In vitro genotoxicity of para-phenylenediamine and its N-monoacetyl or N,N'-diacetyl metabolites.
Garrigue JL; Ballantyne M; Kumaravel T; Lloyd M; Nohynek GJ; Kirkland D; Toutain H
Mutat Res; 2006 Sep; 608(1):58-71. PubMed ID: 16807077
[TBL] [Abstract][Full Text] [Related]
26. The effect of dose rate on X-radiation-induced mutant frequency and the nature of DNA lesions in mouse lymphoma L5178Y cells.
Evans HH; Nielsen M; Mencl J; Horng MF; Ricanati M
Radiat Res; 1990 Jun; 122(3):316-25. PubMed ID: 2356286
[TBL] [Abstract][Full Text] [Related]
27. Mutation induction and DNA adduct formation in Chinese hamster ovary cells treated with 6-nitrochrysene, 6-aminochrysene and their metabolites.
Delclos KB; Heflich RH
Mutat Res; 1992 Jun; 279(3):153-64. PubMed ID: 1377330
[TBL] [Abstract][Full Text] [Related]
28. Genotoxicity of naturally occurring indole compounds: correlation between covalent DNA binding and other genotoxicity tests.
Reddy MV; Storer RD; Laws GM; Armstrong MJ; Barnum JE; Gara JP; McKnight CG; Skopek TR; Sina JF; DeLuca JG; Galloway SM
Environ Mol Mutagen; 2002; 40(1):1-17. PubMed ID: 12211071
[TBL] [Abstract][Full Text] [Related]
29. Absence of DNA adduct formation by phenobarbital, polychlorinated biphenyls, and chlordane in mouse liver using the 32P-postlabeling assay.
Whysner J; Montandon F; McClain RM; Downing J; Verna LK; Steward RE; Williams GM
Toxicol Appl Pharmacol; 1998 Jan; 148(1):14-23. PubMed ID: 9465259
[TBL] [Abstract][Full Text] [Related]
30. The third United Kingdom Environmental Mutagen Society collaborative trial: overview, a summary and assessment.
Arlett CF; Cole J
Mutagenesis; 1990; 5 Suppl():85-8. PubMed ID: 2184327
[TBL] [Abstract][Full Text] [Related]
31. In vitro biotransformation and genotoxicity of the drinking water disinfection byproduct bromodichloromethane: DNA binding mediated by glutathione transferase theta 1-1.
Ross MK; Pegram RA
Toxicol Appl Pharmacol; 2004 Mar; 195(2):166-81. PubMed ID: 14998683
[TBL] [Abstract][Full Text] [Related]
32. Uranyl acetate induces hprt mutations and uranium-DNA adducts in Chinese hamster ovary EM9 cells.
Stearns DM; Yazzie M; Bradley AS; Coryell VH; Shelley JT; Ashby A; Asplund CS; Lantz RC
Mutagenesis; 2005 Nov; 20(6):417-23. PubMed ID: 16195314
[TBL] [Abstract][Full Text] [Related]
33. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
Blair IA; Oe T; Kambouris S; Chaudhary AK
Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of benzidine to N-hydroxy-N,N'-diacetylbenzidine and subsequent nucleic acid binding and mutagenicity.
Morton KC; King CM; Baetcke KP
Cancer Res; 1979 Aug; 39(8):3107-13. PubMed ID: 455295
[No Abstract] [Full Text] [Related]
35. Binding of N-acetylbenzidine and N,N'-diacetylbenzidine to hepatic DNA of rat and hamster in vivo and in vitro.
Kennelly JC; Beland FA; Kadlubar FF; Martin CN
Carcinogenesis; 1984 Mar; 5(3):407-12. PubMed ID: 6705145
[TBL] [Abstract][Full Text] [Related]
36. The mutagenicity of 5-azacytidine and other inhibitors of replicative DNA synthesis in the L5178Y mouse lymphoma cell.
Amacher DE; Turner GN
Mutat Res; 1987 Jan; 176(1):123-31. PubMed ID: 2432424
[TBL] [Abstract][Full Text] [Related]
37. A comparative study of TK6 human lymphoblastoid and L5178Y mouse lymphoma cell lines in the in vitro micronucleus test.
Zhang LS; Honma M; Hayashi M; Suzuki T; Matsuoka A; Sofuni T
Mutat Res; 1995 Aug; 347(3-4):105-15. PubMed ID: 7565900
[TBL] [Abstract][Full Text] [Related]
38. Carcinogen-DNA adduct formation as a predictor of metabolic activation pathways and reactive intermediates in benzidine carcinogenesis.
Kadlubar FF; Yamazoe Y; Lang NP; Chu DZ; Beland FA
Adv Exp Med Biol; 1986; 197():537-49. PubMed ID: 3766280
[No Abstract] [Full Text] [Related]
39. Mutagenic response of mouse lymphoma cells after activation of benzidine and 2-aminofluorene with purified prostaglandin H synthase.
Sarkar FH; Radcliff G; Callewaert DM; Marnett LJ; Eling T; Daston DS; Caspary WJ
Mutat Res; 1990 Dec; 242(4):319-28. PubMed ID: 2123966
[TBL] [Abstract][Full Text] [Related]
40. Binding of benzidine, N-acetylbenzidine, N, N'-diacetylbenzidine and Direct Blue 6 to rat liver DNA.
Martin CN; Beland FA; Kennelly JC; Kadlubar FF
Environ Health Perspect; 1983 Mar; 49():101-6. PubMed ID: 6832087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
